Moyamoya Brain

Contrasting Cerebral Hyperperfusion Patterns in Moyamoya Disease Versus Atherosclerotic Occlusive Cerebrovascular Disease: Insights From Day-One 99m Tc-ECD SPECT After Revascularization.

Neurocognitive profile of pediatric moyamoya disease with posterior cerebral artery involvement.

OBJECTIVE: While posterior cerebral artery (PCA) involvement in moyamoya disease (MMD) is associated

Delayed Recognition and Stroke-Predominant Presentation in Down Syndrome-Associated Moyamoya Syndrome.

BACKGROUND: Children with Down syndrome (DS) are at high risk for moyamoya syndrome (MMS) and ischem

Thalamic anastomosis as a potential marker of perioperative ischemic risk in moyamoya disease.

Revascularization surgery is a well-established intervention for both ischemic and hemorrhagic moyam

Comorbidities in sickle cell disease by age in the Indiana sickle cell data collection (IN-SCDC).

OBJECTIVE: Survival for individuals with sickle cell disease (SCD) is increasing, and along with it

Moyamoya disease and angiogenesis: a quantitative analysis of key angiogenic markers.

Moyamoya disease (MMD) is a cerebrovascular condition characterized by progressive narrowing of the

Acetazolamide-challenged ASL shows comparable performance to CT perfusion for angiographic outcomes in moyamoya angiopathy.

BACKGROUND: Moyamoya angiopathy is a chronic steno-occlusive cerebrovascular disorder in which asses

Extracranial-to-intracranial conversion: postoperative vascular remodeling in moyamoya disease after revascularization.

OBJECTIVE: Effective revascularization in moyamoya disease (MMD) entails not only the formation of e

Superficial temporal artery dilation and the risk of transient neurological events after revascularization for moyamoya disease: Impact of preoperative PCA stenosis.

OBJECTIVE: The superficial temporal artery (STA)-to-middle cerebral artery (MCA) anastomosis is an e

Integrated Serum Multiomics Reveal Subtype-Specific Immune Dysregulation and Sex-Dimorphic Pathophysiology in Moyamoya Disease.

BACKGROUND: Moyamoya disease (MMD) is a rare cerebrovascular disorder with unknown pathogenesis, par

A case of anterior cranial fossa dural arteriovenous fistula concomitant with moyamoya disease.

Moyamoya disease is rarely complicated by other cerebrovascular diseases. A man in his 60s presented

Exploratory profiling of serum small extracellular vesicle-associated miRNAs as candidate biomarkers for Moyamoya disease.

PURPOSE: Moyamoya disease (MMD) is a chronic progressive cerebrovascular disease with elevated rates

Impaired cerebral autoregulation in patients with moyamoya disease and moyamoya syndrome: A prospective cross-sectional study.

Moyamoya disease and syndrome (MMDS) are rare cerebrovascular etiologies defined by stenosis of the

The effectiveness of indirect revascularization on haemorrhagic moyamoya disease and the activities that trigger intracranial haemorrhage: a comprehensive study - A letter.

Association between pre-operative long-term aspirin use and post-operative outcomes following extracranial-intracranial bypass for moyamoya disease: National Inpatient Sample analysis.

OBJECTIVE: Moyamoya disease (MMD) carries significant morbidity. While management focuses on treatme

Long-term outcomes of nonsurgical management alone for adult patients with ischemic moyamoya disease without cerebral misery perfusion: combined analyses of two prospective cohorts.

INTRODUCTION: The most appropriate method to manage adult patients with ischemic-onset moyamoya dise